{"id":"https://openalex.org/W1502421189","doi":"https://doi.org/10.1111/j.1368-5031.2005.00565.x","title":"Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease","display_name":"Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease","alternate_titles":[],"publication_year":2005,"publication_date":"2005-05-25","ids":{"openalex":"https://openalex.org/W1502421189","doi":"https://doi.org/10.1111/j.1368-5031.2005.00565.x","mag":"1502421189","pmid":"https://pubmed.ncbi.nlm.nih.gov/15924587"},"language":"en","primary_location":{"id":"doi:10.1111/j.1368-5031.2005.00565.x","doi":"https://doi.org/10.1111/j.1368-5031.2005.00565.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1368-5031.2005.00565.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1368-5031.2005.00565.x","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1502421189"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1368-5031.2005.00565.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066244222","display_name":"Jos\u00e9 Mar\u00eda Cruz-Fern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I79238269","display_name":"Universidad de Sevilla","ror":"https://ror.org/03yxnpp24","country_code":"ES","type":"education","lineage":["https://openalex.org/I79238269"]}],"countries":["ES","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. M. CRUZ-Fern\u00e1ndez","raw_affiliation_strings":["Universidad de Sevilla, Sevilla, Spain. jmcruzfer@telefonica.net","MSD (United States), Kenilworth, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Sevilla, Sevilla, Spain. jmcruzfer@telefonica.net","institution_ids":["https://openalex.org/I79238269"]},{"raw_affiliation_string":"MSD (United States), Kenilworth, United States","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070510232","display_name":"Gabriella Bedarida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I79238269","display_name":"Universidad de Sevilla","ror":"https://ror.org/03yxnpp24","country_code":"ES","type":"education","lineage":["https://openalex.org/I79238269"]}],"countries":["ES","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. V. Bedarida","raw_affiliation_strings":["Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","MSD (United States), Kenilworth, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I79238269"]},{"raw_affiliation_string":"MSD (United States), Kenilworth, United States","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091052563","display_name":"J. Adgey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I79238269","display_name":"Universidad de Sevilla","ror":"https://ror.org/03yxnpp24","country_code":"ES","type":"education","lineage":["https://openalex.org/I79238269"]}],"countries":["ES","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Adgey","raw_affiliation_strings":["Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","MSD (United States), Kenilworth, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I79238269"]},{"raw_affiliation_string":"MSD (United States), Kenilworth, United States","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025087068","display_name":"Christian Allen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I79238269","display_name":"Universidad de Sevilla","ror":"https://ror.org/03yxnpp24","country_code":"ES","type":"education","lineage":["https://openalex.org/I79238269"]}],"countries":["ES","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Allen","raw_affiliation_strings":["Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","MSD (United States), Kenilworth, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I79238269"]},{"raw_affiliation_string":"MSD (United States), Kenilworth, United States","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021709407","display_name":"Amy O. Johnson\u2010Levonas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I79238269","display_name":"Universidad de Sevilla","ror":"https://ror.org/03yxnpp24","country_code":"ES","type":"education","lineage":["https://openalex.org/I79238269"]}],"countries":["ES","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. O. Johnson-Levonas","raw_affiliation_strings":["Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","MSD (United States), Kenilworth, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I79238269"]},{"raw_affiliation_string":"MSD (United States), Kenilworth, United States","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033051531","display_name":"Rachid Massaad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I79238269","display_name":"Universidad de Sevilla","ror":"https://ror.org/03yxnpp24","country_code":"ES","type":"education","lineage":["https://openalex.org/I79238269"]}],"countries":["ES","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Massaad","raw_affiliation_strings":["Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","MSD (United States), Kenilworth, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad de Sevilla,1Hospital Virgen Macarena, Sevilla, Spain, Ludwig Maxmilians Universitaet,2Mu\u0308enchen, Germany, The Royal Hospitals,3Regional Medical Cardiology Centre, Belfast, Northern Ireland, Merck Research Laboratories,4Rahway, NJ, USA Merck Sharpe & Dohme,6Brussels, Belgium, Merck & Co. Inc,5Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I79238269"]},{"raw_affiliation_string":"MSD (United States), Kenilworth, United States","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5066244222"],"corresponding_institution_ids":["https://openalex.org/I1285764155","https://openalex.org/I79238269"],"apc_list":{"value":2350,"currency":"USD","value_usd":2350},"apc_paid":null,"fwci":5.3175,"has_fulltext":true,"cited_by_count":58,"citation_normalized_percentile":{"value":0.95803129,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"59","issue":"6","first_page":"619","last_page":"627"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":1.0},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":1.0},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.7039999961853027},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9729999899864197},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":1.0},{"id":"https://openalex.org/keywords/combination-lipid-lowering-therapy","display_name":"combination lipid-lowering therapy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/ldl-c-target-attainment","display_name":"LDL-C goal attainment","score":0.7200000286102295},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.8899999856948853},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.8849999904632568},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8840000033378601},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6499999761581421},{"id":"https://openalex.org/keywords/statin-combination-therapy","display_name":"statin combination therapy","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9400924444198608},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.9223467111587524},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.8497040271759033},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.5885704755783081},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5655173659324646},{"id":"https://openalex.org/C3018906752","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary heart disease","level":2,"score":0.5551860928535461},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5524762868881226},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.484928160905838},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4526814818382263},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43823105096817017},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.4185217022895813},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3427949547767639},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.25044578313827515},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1368-5031.2005.00565.x","doi":"https://doi.org/10.1111/j.1368-5031.2005.00565.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1368-5031.2005.00565.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1368-5031.2005.00565.x","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},{"id":"pmid:15924587","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15924587","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical practice","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1111/j.1368-5031.2005.00565.x","doi":"https://doi.org/10.1111/j.1368-5031.2005.00565.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1368-5031.2005.00565.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1368-5031.2005.00565.x","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1502421189.pdf","grobid_xml":"https://content.openalex.org/works/W1502421189.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W81463456","https://openalex.org/W137344628","https://openalex.org/W424467158","https://openalex.org/W1554387723","https://openalex.org/W1778499707","https://openalex.org/W1970435447","https://openalex.org/W1976212953","https://openalex.org/W1981798840","https://openalex.org/W1987507883","https://openalex.org/W2022842079","https://openalex.org/W2024334311","https://openalex.org/W2029963488","https://openalex.org/W2038780541","https://openalex.org/W2042873619","https://openalex.org/W2052405351","https://openalex.org/W2086228842","https://openalex.org/W2087666829","https://openalex.org/W2106343349","https://openalex.org/W2116404316","https://openalex.org/W2123793996","https://openalex.org/W2128481065","https://openalex.org/W2136295087","https://openalex.org/W2137343899","https://openalex.org/W2140072878","https://openalex.org/W2153788691","https://openalex.org/W2159449551","https://openalex.org/W2166910397","https://openalex.org/W2168876694","https://openalex.org/W2741033020","https://openalex.org/W4238251256","https://openalex.org/W4249825849","https://openalex.org/W4285719527","https://openalex.org/W4302510132"],"related_works":["https://openalex.org/W2087274346","https://openalex.org/W1981798840","https://openalex.org/W2001375687","https://openalex.org/W1992197441","https://openalex.org/W2136295087","https://openalex.org/W2330890882","https://openalex.org/W1482078817","https://openalex.org/W1987507883","https://openalex.org/W7217342079","https://openalex.org/W1973858585"],"abstract_inverted_index":{"This":[0],"randomised,":[1],"double-blind,":[2],"placebo":[3],"(PBO)-controlled":[4],"study":[5],"evaluated":[6],"the":[7],"efficacy":[8],"and":[9,71,81,150,165],"safety":[10,173],"of":[11,48,126,163],"ezetimibe":[12],"(EZE)":[13],"co-administered":[14],"with":[15,24,67,110,128,170],"ongoing":[16,129],"atorvastatin":[17],"(ATV)":[18],"therapy":[19],"in":[20,141],"450":[21],"hypercholesterolemic":[22],"patients":[23,66,101],"coronary":[25],"heart":[26],"disease":[27],"(CHD)":[28],"who":[29],"had":[30],"not":[31],"achieved":[32,102],"their":[33],"low-density":[34],"lipoprotein":[35,147],"cholesterol":[36,148],"(LDL-C)":[37],"goal":[38,105],"<":[39,72,106,118,135,157],"or":[40,51,56,73,90,107,119,136,158],"=2.60":[41],"mmol/l":[42,70,75,109],"while":[43,95],"on":[44],"a":[45,60],"stable":[46],"dose":[47,80],"ATV":[49,79,130,166,177],"10":[50,88],"20":[52],"mg/day":[53],"for":[54,92],">":[55],"=6":[57],"weeks.":[58],"After":[59],"4-week":[61],"diet/baseline":[62],"active":[63],"run-in":[64],"period,":[65],"LDL-C":[68,104],">2.60":[69],"=4.20":[74],"were":[76],"stratified":[77],"by":[78],"randomised":[82],"(1":[83],":":[84],"1)":[85],"to":[86,123,132,176],"EZE":[87,111,127,164],"mg":[89],"PBO":[91,113],"6":[93],"weeks":[94],"continuing":[96],"open-label":[97],"ATV.":[98],"Significantly":[99],"more":[100],"an":[103,171],"=2.6":[108],"than":[112],"(81.3":[114],"vs.":[115],"21.8%;":[116],"p":[117],"=":[120,137,159],"0.001).":[121],"Compared":[122],"PBO,":[124],"co-administration":[125],"led":[131],"significantly":[133,155],"(p":[134,156],"0.001)":[138],"greater":[139],"reductions":[140],"LDL-C,":[142],"total":[143],"cholesterol,":[144],"triglycerides,":[145],"non-high-density":[146],"(non-HDL-C),":[149],"apolipoprotein":[151],"B;":[152],"HDL-C":[153],"was":[154,167],"0.05)":[160],"increased.":[161],"Co-administration":[162],"well":[168],"tolerated,":[169],"overall":[172],"profile":[174],"similar":[175],"alone.":[178]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1502421189","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
